Navigation Links
Mirus Bio Releases for Sale TransIT(R)-2020; a New Broad Spectrum, Animal-Free Transfection Reagent to Go Head to Head With FuGENE(R) HD and Lipofectamine(TM) 2000
Date:9/8/2009

MADISON, Wis., Sept. 8 /PRNewswire/ -- From the transfection experts, Mirus Bio introduces its next generation transfection reagent, TransIT(R)-2020 Transfection Reagent.

Mirus has expanded its transfection expertise with the development of a high performance, animal-free, broad spectrum DNA transfection reagent which offers users:

  • Superior Performance--TransIT(R)-2020 outperforms FuGENE(R) HD, Lipofectamine(TM) 2000 and Lipofectamine(TM) 2000 CD in many cell types.
  • Broad Spectrum DNA Delivery--Achieve high transgene expression in many cell types, including hard to transfect cells.
  • Animal Origin free-- TransIT(R)-2020 provides high performance with maximum compatibility.
  • Scientifically Proven--Developed by Mirus Bio scientists with over 15 years of gene delivery expertise.

Visit www.mirusbio.com for all your transfection needs including data, protocols, technical support or to place an order.

The Transfection Experts

For over a decade, Mirus pioneered scientific breakthroughs in non-viral gene delivery. These advancements established our products as industry leading transfection reagents. At Mirus, we continue to grow our expertise in nucleic acid delivery research and products to better serve you.


'/>"/>
SOURCE Mirus Bio LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
3. Engageon Releases First Peer-to-Peer Medical Association Social Network
4. Next Safety Releases Advanced Respirator for Infectious Diseases
5. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
6. PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
9. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
10. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
11. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van Mensvoort ... Nature, at the University of Technology in Eindhoven - has written a ... letter, he calls on humanity to avoid becoming a slave and victim to ... ... Dutch philosopher Koert van Mensvoort – founder of the Next ...
(Date:4/19/2017)... ... 18, 2017 , ... The Vibrating Orifice Aerosol Generator (VOAG) ... monodisperse droplets of known diameters for research applications such as for calibrating droplet ... drying monodisperse droplets. , The VOAG requires forcing liquid out of an ...
(Date:4/19/2017)... ... April 18, 2017 , ... ... Labs . The move comes after the company changed focus to making analytical ... new brand and our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, ...
(Date:4/19/2017)... (PRWEB) , ... April 19, 2017 , ... ... Clostridium difficile (C. diff) infections through education and advocacy. Founded in 2010 ... to a C. diff infection, the foundation has become the most-consulted source for ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 30.37% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):